Nov 17, 2020 / 01:00PM GMT
Operator
Greetings, and welcome to the Alkermes conference call to discuss regulatory update for ALKS 3831. My name is Melissa, and I'll be your operator for today's call. (Operator Instructions) Please note that this call is being recorded.
Now I'll turn the call over to Sandra Coombs, Vice President of Investor Relations. Sandy, you may begin.
Sandra Coombs - Alkermes plc - Co-Head of IR
Thank you. Welcome to the Alkermes plc conference call to discuss the regulatory update for ALKS 3831. With me today are Richard Pops, our CEO; and Heather Faulds, our Senior Vice President of Regulatory Affairs.
Before we begin, let me remind you that our discussions during this conference call will include forward-looking statements relating to, among other things, our expectations concerning next steps in the regulatory review and potential approval of ALKS 3831. These forward-looking statements are neither promises nor guarantees and are subject to a high degree of uncertainty and risk. Please see our press release issued this morning and our most recent annual
Alkermes Plc to Discuss Regulatory Update for ALKS 3831 - Conference Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot